Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model-Reference-Cited by-同舟云学术

Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model

Published:2022-07 Issue: Volume:539 Page:215722
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Li Pan,Rozich Noah,Wang Jianxin,Wang Junke,Xu Yao,Herbst Brian,Yu Raymond,Muth Stephen,Niu Nan,Li Keyu,Funes Vanessa,Gai Jessica,Osipov Arsen,Edil Barish H.,Wolfgang Christopher L.,Lei Ming,Liang Tingbo,Zheng Lei^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Cancer statistics, 2021;Siegel;CA A Cancer J. Clin.,2021

2. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma;Fan;Mol. Cancer,2020

3. The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities;Ho;Nat. Rev. Clin. Oncol.,2020

4. Pancreatic cancer;Hidalgo;N. Engl. J. Med.,2010

5. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N. Engl. J. Med.,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Interleukins in Pancreatic Cancer: A Literature Review;Journal of Gastrointestinal Cancer;2024-09-11

2. Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration;Journal of Hematology & Oncology;2024-08-07

3. The role of targeting CDK4/6 in cancer immunotherapy;Holistic Integrative Oncology;2024-06-27

4. Current and future immunotherapeutic approaches in pancreatic cancer treatment;Journal of Hematology & Oncology;2024-06-04

5. Neutrophils in pancreatic ductal adenocarcinoma: bridging preclinical insights to clinical prospects for improved therapeutic strategies;Expert Review of Clinical Immunology;2024-05-07